Artificial Heart-Lung Machine Market Size, Share, Trends, Growth and Forecast 2032

Artificial Heart-Lung Machine Market Insights

Zion Market Research has published a report on the global Artificial Heart-Lung Machine Market, estimating its value at USD 387.2 Million in 2023, with projections indicating that it will reach USD 608.56 Million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 4.6% over the forecast period 2024-2032.

The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Artificial Heart-Lung Machine Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Artificial Heart-Lung Machine Market: An Overview

An artificial heart-lung machine is also referred to as a cardiopulmonary bypass pump. It plays a role in the heart & lungs during the performing of heart surgery. While performing surgery, it becomes difficult for surgeons for operating on heartbeats. Hence, heart-lung equipment is attached to veins and it helps the blood in bypassing the heart at the time of performing heart surgery. Apparently, the device pulls the blood from the body of the patient before it reaches the heart and then adds oxygen to that blood. After that, the device Heart pumps the oxygenated blood into the body of the patient. For instance, special tubes are attached to the body of the patient for pushing the oxygenated blood throughout the patient’s body. The product is utilized during heart transplantation and while performing complicated surgeries on the lungs.

Additionally, developing countries are emphasizing the expansion of healthcare infrastructure and an increase in the number of specialized cardiac centers, subsequently boosting the heart-lung machine market. Technological advancements, such as the development of miniaturized and portable systems, improved biocompatibility of components, and enhanced monitoring capabilities, will improve the efficiency of cardiac surgeries. Therefore, with the increasing healthcare expenditure, growing disposable income, aging population, and rising adoption of heart-lung machines.

Artificial Heart-Lung Machine Market: Growth Drivers

A surge in the proportion of heart surgeries and an increase in heart transplantations along with growing cases of complicated lung operations will steer the expansion of the artificial heart-lung machine industry over the forecast timeframe. Rapid healthcare infrastructural growth and an increase in the diagnosis & treatment of heart ailments will create lucrative growth avenues for the artificial heart-lung machine market in the years ahead. Nonetheless, the expansion of the artificial heart-lung machine industry is likely to be obstructed as a result of huge equipment costs and cardiopulmonary bypass risks along with the low availability of healthcare experts. However, large-scale funding of research activities by major participants and technological breakthroughs are some of the major factors that will not only nullify the market hindrances but will supplement the business landscape.

Furthermore, a prominent rise in the aging population is anticipated to boost the expansion of the artificial heart lung machine industry over the assessment timeframe. Growing awareness pertaining to heart equipment will proliferate the popularity of the artificial heart-lung machine in the years to come. The rise in government funding for the healthcare industry will open new vistas of growth for the artificial heart and lung machine industry in the years ahead.

North American Market To Register Humungous Growth Over 2024-2032

The expansion of the artificial heart lung machine industry over the forecast timeline is attributed to rising in the cases of heart ailments witnessed in the region. In addition to this, rapid technological breakthroughs, the surge in product awareness among the populace of the region, and the rise in the acceptance of minimally invasive methods will create huge growth avenues for the artificial heart-lung machine market in the sub-continent over the years ahead. Reportedly, CDC has predicted heart disorder to be the major cause of death in the U.S.

To know more about this report, Request a FREE sample copy

Artificial Heart-Lung Machine Market: Report Scope

Key participants profiled in the study are -

• Jarvik Heart
• Sorin Group
• SynCardia
• Medtronic Inc
• C.R. Bard Inc
• Edwards Lifesciences
• MAQUET GmbH & Co. KG
• Terumo Corporation
• Tianjin Medical
• Braile Biomedica.

The global artificial heart-lung machine market is segmented as follows:

By type:

• Single Roller Pump
• Double Roller Pump

By application:

• Lung Transplantation Operations
• Cardiac Surgery
• Acute Respiratory Failure Treatment
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of The Middle East & Africa